Host defense pathways against fungi: The basis for vaccines and immunotherapy

Frontiers in Microbiology

Volumn 3, Issue MAY, 2012, Pages

  Carvalho, Agostinho ^a,b,c   Cunha, Cristina ^a   Iannitti, Rossana G ^a   Casagrande, Andrea ^a,d   Bistoni, Francesco ^a   Aversa, Franco ^e   Romani, Luigina ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MINHO   (Portugal)

^c UNIVERSITY OF MINHO   (Portugal)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

Author keywords

Fungi; Immune responses; Immunotherapy; Vaccines; Vaccinomics

Indexed keywords

EID: 84868273951     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00176     Document Type: Short Survey

References (53)

1. Beenhouwer, D. O., Yoo, E. M., Lai, C. W., Rocha, M. A., and Morrison, S. L. (2007). Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infect. Immun. 75, 1424-1435.
2. Bonifazi, P., Zelante, T., D'Angelo, C., De Luca, A., Moretti, S., Bozza, S., Perruccio, K., Iannitti, R. G., Giovannini, G., Volpi, C., Fallarino, F., Puccetti, P., and Romani, L. (2009). Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol. 2, 362-374.
3. Bozza, S., Clavaud, C., Giovannini, G., Fontaine, T., Beauvais, A., Sarfati, J., D'Angelo, C., Perruccio, K., Bonifazi, P., Zagarella, S., Moretti, S., Bistoni, F., Latge, J. P., and Romani, L. (2009). Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J. Immunol. 183, 2407-2414.
4. Bromuro, C., Romano, M., Chiani, P., Berti, F., Tontini, M., Proietti, D., Mori, E., Torosantucci, A., Costantino,P.,Rappuoli,R.,and Cassone,A. (2010). Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 28, 2615-2623.
5. Carvalho, A., Cunha, C., Bistoni, F., and Romani, L. (2012a). Immunotherapy of aspergillosis. Clin. Microbiol. Infect. 18, 120-125.
6. Carvalho, A., De Luca, A., Bozza, S., Cunha, C., D'Angelo, C., Moretti, S., Perruccio, K., Iannitti, R. G., Fallarino, F., Pierini, A., Latge, J. P., Velardi, A., Aversa, F., and Romani, L. (2012b). TLR3 essentially promotes protective class I-restricted memory CD8 T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. Blood 119, 967-977.
7. Carvalho, A., Cunha, C., Pasqualotto, A. C., Pitzurra, L., Denning, D. W., and Romani, L. (2010). Genetic variability of innate immunity impacts human susceptibility to fungal diseases. Int. J. Infect. Dis. 14, e460- e468.
8. Casadevall,A.,and Pirofski,L.A. (2003). The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1, 17-24.
9. Casadevall,A.,and Pirofski,L.A. (2012). A new synthesis for antibodymediated immunity. Nat. Immunol. 13, 21-28.
10. Cassone,A. (2008). Fungal vaccines: real progress from real challenges. Lancet Infect. Dis. 8, 114-124.
11. Cassone, A., and Rappuoli, R. (2010). Universal vaccines: shifting to one for many. MBio 1, e00042-10.
12. Cavassani,K. A.,Campanelli,A. P.,Moreira, A. P., Vancim, J. O., Vitali, L. H., Mamede, R. C., Martinez, R., and Silva, J. S. (2006). Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J. Immunol. 177, 5811-5818.
13. Cenci, E., Mencacci, A., Bacci, A., Bistoni, F., Kurup,V. P., and Romani, L. (2000). T cell vaccination in mice with invasive pulmonary spergillosis. J. Immunol. 165, 381-388.
14. Cohen, N. R., Tatituri, R. V., Rivera, A., Watts, G. F., Kim, E. Y., Chiba, A., Fuchs, B. B., Mylonakis, E., Besra, G. S., Levitz, S. M., Brigl, M., and Brenner, M. B. (2011). Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 10, 437-450.
15. Cunha, C., and Carvalho, A. (2012). Host genetics and invasive fungal diseases: towards improved diagnosis and therapy? Expert Rev. Anti. Infect. Ther. 10, 257-259.
16. Cutler, J. E., Deepe, G. S. Jr., and Klein, B. S. (2007). Advances in combating fungal diseases: vaccines on the threshold. Nat. Rev. Microbiol. 5, 13-28.
17. de Bastos Ascenco Soares, R., Gomez, F. J., De Almeida Soares, C. M., and Deepe, G. S. Jr. (2008). Vaccination with heat shock protein 60 induces a protective immune response against experimental Paracoccidioides brasiliensis pulmonary infection. Infect. Immun. 76, 4214-4221.
18. De Luca, A., Iannitti, R. G., Bozza, S., Beau, R., Casagrande, A., D'Angelo, C., Moretti, S., Cunha, C., Giovannini, G., Massi-Benedetti, C., Carvalho, A., Boon, L., Latge, J. P., and Romani, L. (2012). CD4 T cell vaccination overcomes defective cross-presentation of fungal antigens in murine chronic granulomatous disease. J. Clin. Invest. doi: 10.1172/JCI60862. [Epub ahead of print].
19. De Luca, A., Zelante, T., D'Angelo, C., Zagarella, S., Fallarino, F., Spreca, A., Iannitti, R. G., Bonifazi, P., Renauld, J. C., Bistoni, F., Puccetti, P., and Romani, L. (2010). IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3, 361-373.
20. Deepe, G. S. Jr., and Gibbons, R. S. (2002). Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum. Infect. Immun. 70, 3759-3767.
21. Deepe, G. S. Jr., and Gibbons, R. S. (2008). TNF-alpha antagonism generates a population of antigenspecific CD4+ CD25+ T cells that inhibit protective immunity in murine histoplasmosis. J. Immunol. 180, 1088-1097.
22. Diaz-Arevalo, D., Bagramyan, K., Hong, T. B., Ito, J. I., and Kalkum, M. (2011). CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine. Infect. Immun. 79, 2257-2266.
23. Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A., and Levitz, S. M. (2010). Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded betaglucan particles. MBio 1, e00164-10.
24. Ito, J. I., Lyons, J. M., Hong, T. B., Tamae, D., Liu, Y. K., Wilczynski, S. P., and Kalkum, M. (2006). Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect. Immun. 74, 5075-5084.
25. Kennedy, R. B., and Poland, G. A. (2011). The top five "game changers" in vaccinology: toward rational and directed vaccine development. OMICS 15, 533-537.
26. Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., and Pierce, N. (2003). A trial of a 9valent pneumococcal conjugate vaccine in children with and those without HIV infection. N.Engl.J.Med. 349, 1341-1348.
27. Lam, J. S., Mansour, M. K., Specht, C. A., and Levitz, S. M. (2005). A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J. Immunol. 175, 7496-7503.
28. Levitz, S. M., and Golenbock, D. T. (2012). Beyond empiricism: informing vaccine development through innate immunity research. Cell 148, 1284-1292.
29. Littman, D. R., and Pamer, E. G. (2011). Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 10, 311-323.
30. Loures, F. V., Pina, A., Felonato, M., and Calich, V. L. (2009). TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J. Immunol. 183, 1279-1290.
31. Magliani, W., Conti, S., Frazzi, R., Ravanetti, L., Maffei, D. L., and Polonelli, L. (2005). Protective antifungal yeast killer toxin-like antibodies. Curr.Mol.Med.5, 443-452.
32. Matthews, R. C., Rigg, G., Hodgetts, S., Carter, T., Chapman, C., Gregory, C., Illidge, C., and Burnie, J. (2003). Preclinical assessment of the efficacy of mycograb,a human recombinant antibody against fungal HSP90. Antimicrob. Agents Chemother. 47, 2208-2216.
33. Nanjappa, S. G., Heninger, E.,Wuthrich, M., Sullivan, T., and Klein, B. (2012). Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice. J. Clin. Invest. 122, 987-999.
34. Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L. S., Jones, R. G., and Choi, Y. (2009). Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460, 103-107.
35. Poland, G. A., and Oberg, A. L. (2010). Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology. Vaccine 28, 3509-3510.
36. Pulendran, B., and Ahmed, R. (2011). Immunological mechanisms of vaccination. Nat. Immunol. 12, 509-517.
37. Pulendran, B., Li, S., and Nakaya, H. I. (2010). Systems vaccinology. Immunity 33, 516-529.
38. Rachini, A., Pietrella, D., Lupo, P., Torosantucci, A., Chiani, P., Bromuro, C., Proietti, C., Bistoni, F., Cassone, A., and Vecchiarelli, A. (2007). An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infect. Immun. 75, 5085-5094.
39. Romani, L. (2011). Immunity to fungal infections. Nat. Rev. Immunol. 11, 275-288.
40. Romani, L., and Puccetti, P. (2006). Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol. 14, 183-189.
41. Sallusto, F., Lanzavecchia, A., Araki, K., and Ahmed, R. (2010). From vaccines to memory and back. Immunity 33, 451-463.
42. Schneider, D. S., and Ayres, J. S. (2008). Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8, 889-895.
43. Segal, B. H. (2009). Aspergillosis. N. Engl.J.Med.360, 1870-1884.
44. Shubitz, L. F., Yu, J. J., Hung, C. Y., Kirkland, T. N., Peng, T., Perrill, R., Simons, J., Xue, J., Herr, R. A., Cole, G. T., and Galgiani, J. N. (2006). Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein. Vaccine 24, 5904-5911.
45. Spellberg, B. (2011). Vaccines for invasive fungal infections. F1000 Med. Rep. 3, 13.
46. Spellberg, B., Ibrahim, A. S., Lin, L., Avanesian, V., Fu, Y., Lipke, P., Otoo, H., Ho, T., and Edwards, J. E. Jr. (2008). Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cellmediated immunity. J. Infect. Dis. 197, 967-971.
47. Stuehler, C., Khanna, N., Bozza, S., Zelante, T., Moretti, S., Kruhm, M., Lurati, S., Conrad, B., Worschech, E., Stevanovic, S., Krappmann, S., Einsele, H., Latge, J. P., Loeffler, J., Romani, L., and Topp, M. S. (2011). Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 117, 5881-5891.
48. Tarcha, E. J., Basrur, V., Hung, C. Y., Gardner, M. J., and Cole, G. T. (2006). A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice. Infect. Immun. 74, 516-527.
49. Torosantucci, A., Bromuro, C., Chiani, P., De Bernardis, F., Berti, F., Galli, C., Norelli, F., Bellucci, C., Polonelli, L., Costantino, P., Rappuoli, R., and Cassone, A. (2005). A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 202, 597-606.
50. van der Windt, G. J., Everts, B., Chang, C. H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., and Pearce, E. L. (2012). Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36, 68-78.
51. Wuthrich, M., Filutowicz, H. I., Warner, T., Deepe, G. S. Jr., and Klein, B. S. (2003). Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J. Exp. Med. 197, 1405-1416.
52. Wuthrich, M., Gern, B., Hung, C.Y., Ersland, K., Rocco, N., Pick-Jacobs, J., Galles, K., Filutowicz, H., Warner, T., Evans, M., Cole, G., and Klein, B. (2011). Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J. Clin. Invest. 121, 554-568.
53. Xin, H., Dziadek, S., Bundle, D. R., and Cutler, J. E. (2008). Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc. Natl. Acad. Sci. U.S.A. 105, 13526-13531.